compound tirzepatide doses Compounded (GLP-1/GIP) Tirzepatide / Niacinamide Injection |

Semaglutide is the latest series of treatments for overweight issues and obesity

The appetite suppression that once felt automatic now requires conscious effort to replicate through food choices and meal timing

Type 2 Diabetes & Metabolic Risk Semaglutide was originally FDA-approved as Ozempic for type 2 diabetes it lowers blood sugar by stimulating insulin production in response to meals and suppressing glucagon

A good candidate for Tirzepatide is typically someone with a body mass index (BMI) of 30 or higher, or a BMI of 27 or higher with weight-related health conditions, such as type 2 diabetes, high blood pressure, or high cholesterol

Stopping treatment leads to weight regain